BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1661861)

  • 1. The actions of fentanyl to inhibit drug-induced emesis.
    Barnes NM; Bunce KT; Naylor RJ; Rudd JA
    Neuropharmacology; 1991 Oct; 30(10):1073-83. PubMed ID: 1661861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emetic and antiemetic effects of opioids in the dog.
    Blancquaert JP; Lefebvre RA; Willems JL
    Eur J Pharmacol; 1986 Sep; 128(3):143-50. PubMed ID: 3024991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olvanil: a non-pungent TRPV1 activator has anti-emetic properties in the ferret.
    Chu KM; Ngan MP; Wai MK; Yeung CK; Andrews PL; Percie du Sert N; Rudd JA
    Neuropharmacology; 2010 Feb; 58(2):383-91. PubMed ID: 19825380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of emesis by fentanyl and opioid receptor antagonists in Suncus murinus (house musk shrew).
    Rudd JA; Cheng CH; Naylor RJ; Ngan MP; Wai MK
    Eur J Pharmacol; 1999 Jun; 374(1):77-84. PubMed ID: 10422643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluphenazine, ICS 205-930 and dl-fenfluramine differentially antagonise drug-induced emesis in the ferret.
    Costall B; Domeney AM; Naylor RJ; Owera-Atepo JB; Rudd JA; Tattersall FD
    Neuropharmacology; 1990 May; 29(5):453-62. PubMed ID: 1972549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of dexamethasone with ondansetron on drug-induced emesis in the ferret.
    Rudd JA; Bunce KT; Naylor RJ
    Neuropharmacology; 1996 Jan; 35(1):91-7. PubMed ID: 8684601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of different antiemetic agents on morphine-induced emesis in ferrets.
    Wynn RL; Essien E; Thut PD
    Eur J Pharmacol; 1993 Sep; 241(1):47-54. PubMed ID: 8223924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiemetic effects of YM060, a potent and selective serotonin (5HT)3-receptor antagonist, in ferrets and dogs.
    Kamato T; Miyata K; Ito H; Yuki H; Yamano M; Honda K
    Jpn J Pharmacol; 1991 Nov; 57(3):387-95. PubMed ID: 1813664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets.
    Tattersall FD; Rycroft W; Francis B; Pearce D; Merchant K; MacLeod AM; Ladduwahetty T; Keown L; Swain C; Baker R; Cascieri M; Ber E; Metzger J; MacIntyre DE; Hill RG; Hargreaves RJ
    Neuropharmacology; 1996; 35(8):1121-9. PubMed ID: 9121615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-emetic effects of CP-99,994 in the ferret and the dog: role of the NK1 receptor.
    Watson JW; Gonsalves SF; Fossa AA; McLean S; Seeger T; Obach S; Andrews PL
    Br J Pharmacol; 1995 May; 115(1):84-94. PubMed ID: 7544198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of tachykinin NK-1 receptors in emetic action in the area postrema of ferrets].
    Saito R; Ariumi H; Kubota H; Nago S; Honda K; Takano Y; Kamiya H
    Nihon Yakurigaku Zasshi; 1999 Oct; 114 Suppl 1():209P-214P. PubMed ID: 10629882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of three preclinical models for nausea and vomiting assessment.
    Goineau S; Castagné V
    J Pharmacol Toxicol Methods; 2016; 82():45-53. PubMed ID: 27477617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret.
    Higgins GA; Kilpatrick GJ; Bunce KT; Jones BJ; Tyers MB
    Br J Pharmacol; 1989 May; 97(1):247-55. PubMed ID: 2720310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pica in rats is analogous to emesis: an animal model in emesis research.
    Takeda N; Hasegawa S; Morita M; Matsunaga T
    Pharmacol Biochem Behav; 1993 Aug; 45(4):817-21. PubMed ID: 8415820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DAT-582, a novel serotonin3 receptor antagonist, is a potent and long-lasting antiemetic agent in the ferret and dog.
    Yoshida N; Omoya H; Ito T
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1159-65. PubMed ID: 1532032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3H]ohmefentanyl preferentially binds to mu-opioid receptors but also labels sigma-sites in rat brain sections.
    Wang H; Pélaprat D; Roques BP; Vanhove A; Chi ZQ; Rostène W
    Eur J Pharmacol; 1991 Feb; 193(3):341-50. PubMed ID: 1647320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delta9-tetrahydrocannabinol selectively acts on CB1 receptors in specific regions of dorsal vagal complex to inhibit emesis in ferrets.
    Van Sickle MD; Oland LD; Mackie K; Davison JS; Sharkey KA
    Am J Physiol Gastrointest Liver Physiol; 2003 Sep; 285(3):G566-76. PubMed ID: 12791597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential cardiovascular and respiratory responses to central administration of selective opioid agonists in conscious rabbits: correlation with receptor distribution.
    May CN; Dashwood MR; Whitehead CJ; Mathias CJ
    Br J Pharmacol; 1989 Nov; 98(3):903-13. PubMed ID: 2556206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-emetic effects of a novel NK-1 receptor antagonist HSP-117 in ferrets.
    Saito R; Suehiro Y; Ariumi H; Migita K; Hori N; Hashiguchi T; Sakai M; Saeki M; Takano Y; Kamiya H
    Neurosci Lett; 1998 Oct; 254(3):169-72. PubMed ID: 10214984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Hydroxytryptamine M-receptor antagonism to prevent cisplatin-induced emesis.
    Costall B; Domeney AM; Naylor RJ; Tattersall FD
    Neuropharmacology; 1986 Aug; 25(8):959-61. PubMed ID: 3774121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.